+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II

Bone 48(4): 938-944

Non-canonical pathways of osteoclastogenesis have been described in which several cytokines are able to substitute for RANKL. These cytokines are few in number and their role(s) in pathological bone resorption has not been ascertained. We have identified five additional cytokines, APRIL, BAFF, NGF, IGF I and IGF II, that can induce RANKL-independent osteoclastogenesis. All five cytokines induced both osteoclast differentiation and activation with respect to the formation of significant numbers of TRAP(+) and VNR(+) multinucleated cells that were capable of resorbing bone. The number of TRAP(+) multinucleated cells that formed was in the range of 40-75% of that supported by MCSF plus RANKL. Resorption was at a similar level to that induced by the other known RANKL substitutes TNFα, IL-6 and TGF-β. The addition of osteoprotegrin, the endogenous decoy receptor of RANKL, revealed that this resorption was independent of RANKL. APRIL, BAFF, IGF I and IGF II were found to be expressed in giant cell tumour of bone. IGF I and IGF II demonstrated very strong expression in the stromal cell population of all tumour samples. This data suggests that non-canonical osteoclastogenesis plays a role in both normal and pathological bone resorption.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333203

Download citation: RISBibTeXText

PMID: 21193069

DOI: 10.1016/j.bone.2010.12.023

Related references

LTB4 can directly stimulate human osteoclast formation from PBMC independent of RANKL. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 33(4): 391-403, 2005

Human osteoclast formation and bone resorption by a mechanism independent of RANK/RANKL Role of IL-6 and IL-11. Journal of Bone & Mineral Research 16(Suppl 1): S381, September, 2001

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone (New York) 32(1): 1-7, January, 2003

Activated human T cells induce osteoclast formation from peripheral monocytes via expression of osteoclast differentiation factor /RANKL/TRANCE/OPGL. Arthritis & Rheumatism 42(9 SUPPL ): S154, Sept, 1999

Lipopolysaccharide stimulates osteoclast formation via RANKL expression independent of PGE2 production. Journal of Bone & Mineral Research 17(Suppl 1): S346, September, 2002

IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo. Bone 51(4): 771-780, 2013

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Research and Treatment 105(1): 7-16, 2006

Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clinical Cancer Research 18(2): 326-335, 2012

A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis and Rheumatism 60(11): 3324-3335, 2010

Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics. Bone 69: 80-88, 2015

Proliferation-coupled osteoclast differentiation by RANKL: Cell density as a determinant of osteoclast formation. Bone 81: 392-399, 2016

Osteoclast formation in osteoclast precursor cell line RAW2647 is not correlated to OPG, RANK or RANKL expression, but is influenced by culture conditions. Journal of Bone & Mineral Research 16(Suppl 1): S506, September, 2001

TGF-beta induces human osteoclast formation and bone resorption in the absence of soluble RANKL. Calcified Tissue International 70(4): 250-251, April, 2002

Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency. International Journal of Molecular Medicine 21(2): 233-238, 2008